umifenovir has been researched along with Coxsackie Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Fan, Q; Huang, D; Li, H; Liang, C; Zhang, S; Zhi, C | 1 |
| Deng, H; He, J; Liu, Y; Shi, L; Xiao, H; Yang, Z; Zhong, Q | 1 |
2 other study(ies) available for umifenovir and Coxsackie Virus Infections
| Article | Year |
|---|---|
Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection.
Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; HeLa Cells; Humans; Immunomodulation; Indoles; Interleukin-10; Intracellular Signaling Peptides and Proteins; Mice; Myocarditis; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Spleen | 2017 |
Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo.
Topics: Animals; Antiviral Agents; Cell Line; Coxsackievirus Infections; Enterovirus B, Human; Heart; Humans; Indoles; Inhibitory Concentration 50; Lung; Male; Mice; Mice, Inbred BALB C; Survival Analysis | 2009 |